1260852-84-3 Usage
Uses
Used in Research Applications:
1-(3-fluoro-4-Methoxyphenyl)cyclopropanaMine hydrochloride is used as a research chemical for its potential as a ligand or substrate in various biochemical experiments. Its unique structure allows it to interact with specific biological targets, providing insights into molecular mechanisms and pathways.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 1-(3-fluoro-4-Methoxyphenyl)cyclopropanaMine hydrochloride is used as a potential therapeutic agent for the treatment of certain medical conditions. Its specific chemical properties and interactions with biological systems make it a promising candidate for drug development, offering new avenues for treatment options.
Used in Drug Synthesis:
1-(3-fluoro-4-Methoxyphenyl)cyclopropanaMine hydrochloride can also be used as a key intermediate in the synthesis of other pharmaceutical compounds. Its versatile structure allows for further chemical modifications, enabling the development of new drugs with improved efficacy and selectivity.
Overall, 1-(3-fluoro-4-Methoxyphenyl)cyclopropanaMine hydrochloride is a valuable chemical with diverse applications in research, pharmaceutical development, and drug synthesis. Its unique properties and potential therapeutic effects make it an important compound for further exploration and utilization in the scientific and medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1260852-84-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,8,5 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1260852-84:
(9*1)+(8*2)+(7*6)+(6*0)+(5*8)+(4*5)+(3*2)+(2*8)+(1*4)=153
153 % 10 = 3
So 1260852-84-3 is a valid CAS Registry Number.
1260852-84-3Relevant academic research and scientific papers
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
-
Paragraph 0335-0337, (2021/04/17)
Provided herein, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
